Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (341-350 of 368) with videos related to

Pageof 37
Sort By:
Molecular Carcinogenesis|January 11, 2021
Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARAZheng Wang, Lijun Wen, Ling Zhang, et al.
Blood Cancer Journal|April 24, 2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?Sining Liu, Xinyue Zhang, Haiping Dai, et al.
Cancer Medicine|June 24, 2026
Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST StudyNaoto Takahashi, Dong-Wook Kim, Inho Kim, et al.
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.
Leukemia & Lymphoma|March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantationJinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2022
PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancerYing Wu, Zhe Wang, Lu Han, et al.
Blood|February 26, 2025
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AMLJing Lu, Shengli Xue, Ying Wang, et al.
Discover Oncology|February 21, 2025
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVADJing Lu, Yu Zhu, Huiying Qiu, et al.
Blood Cancer Journal|July 15, 2024
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemiaQian Wu, Xiaofei Yang, Jingren Zhang, et al.
Journal of Hematology & Oncology|November 1, 2022
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialQian Jiang, Zongru Li, Yazhen Qin, et al.
Pageof 37

Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Molecular Carcinogenesis|January 11, 2021
Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARAZheng Wang, Lijun Wen, Ling Zhang, et al.
Blood Cancer Journal|April 24, 2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?Sining Liu, Xinyue Zhang, Haiping Dai, et al.
Cancer Medicine|June 24, 2026
Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST StudyNaoto Takahashi, Dong-Wook Kim, Inho Kim, et al.
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.
Leukemia & Lymphoma|March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantationJinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2022
PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancerYing Wu, Zhe Wang, Lu Han, et al.
Blood|February 26, 2025
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AMLJing Lu, Shengli Xue, Ying Wang, et al.
Discover Oncology|February 21, 2025
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVADJing Lu, Yu Zhu, Huiying Qiu, et al.
Blood Cancer Journal|July 15, 2024
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemiaQian Wu, Xiaofei Yang, Jingren Zhang, et al.
Journal of Hematology & Oncology|November 1, 2022
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialQian Jiang, Zongru Li, Yazhen Qin, et al.
Pageof 37